Why the study?
Does low dose acetylsalicylic acid reduce mortality and myocardial infarction in patients with stable angina and acute coronary syndromes?
Population
Patients with stable angina pectoris and acute coronary syndromes
Design
Review
Authors
Loading...
May support low-dose aspirin in ACS and stable angina; leaves open need for updated RCTs in contemporary populations.
Does low dose acetylsalicylic acid reduce mortality and myocardial infarction in patients with stable angina and acute coronary syndromes?
Low-dose acetylsalicylic acid (75-150 mg daily) effectively reduces the risk of fatal and non-fatal vascular events in patients with stable angina and acute coronary syndromes, with a low incidence of bleeding and gastrointestinal side effects.
Winther et al. (1994) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: